At the heart of producing advanced pharmaceutical compounds lies the meticulous selection and utilization of chemical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier of such critical components, including the vital 3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate. This compound, bearing the CAS number 179688-53-0 and identified by the molecular formula C11H10N2O4, is fundamental to the synthetic pathway leading to Gefitinib, a cornerstone in the treatment of specific types of lung cancer. Its role as a Gefitinib synthesis intermediate underscores the importance of chemical precision in drug manufacturing.

The physical characteristics of 3,4-dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate, an off-white to grey powder, are complemented by its impressive ≥98.0% HPLC purity. This specification is a testament to the rigorous quality control of chemical intermediates that NINGBO INNO PHARMCHEM CO.,LTD. implements. For manufacturers striving for optimal outcomes in pharmaceutical intermediate manufacturing, sourcing materials with such high purity is non-negotiable. These Gefitinib production raw materials are designed to integrate seamlessly into advanced synthetic processes, minimizing side reactions and maximizing yield.

Understanding the chemical and physical properties, such as the boiling point of 452.391°C and a flash point of 227.398°C, is crucial for industrial application. These data points ensure safe and effective handling and processing of the intermediate. NINGBO INNO PHARMCHEM CO.,LTD. provides these details to support clients in their process development and risk management. The consistent supply of high-quality Gefitinib synthesis intermediates is a key factor in maintaining the momentum of pharmaceutical research and development, enabling the continuous production of life-saving drugs.

The expertise of NINGBO INNO PHARMCHEM CO.,LTD. in producing and supplying these essential Gefitinib production raw materials positions us as a valuable partner in the pharmaceutical supply chain. By focusing on the quality control of chemical intermediates, we empower our clients to achieve excellence in their manufacturing endeavors, ultimately contributing to better patient outcomes through the reliable availability of Gefitinib.